The rise and rise of ADHD

Clinical Psychology

Volumn , Issue 40, 2004, Pages 8-13

  Radcliffe, Nick ^a,c   Timimi, Sami ^b  

^a Telfrod/Wrekin Primary Care Trust   (United Kingdom)

^b LINCOLNSHIRE PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; METHYLPHENIDATE;

ATTENTION DEFICIT DISORDER; CHILD; CHILD BEHAVIOR; CLINICAL OBSERVATION; CULTURAL ANTHROPOLOGY; EPIDEMIC; HOSTILITY; HUMAN; LIFESTYLE; NORTH AMERICA; REVIEW; SCORING SYSTEM; SEX RATIO; WESTERN HEMISPHERE;

EID: 4344672622     PISSN: 14738279     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Ainscow, M. & Tweddle, D.A. (1988). Encouraging classroom success. London: Fulton.
2. Angold, A., Erkanli, A., Egger, H.L. & Costello, E.J. (2000). Stimulant treatment for children: A community perspective. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 975-984.
3. Baldwin, S. & Anderson, R. (2000). The cult of methylphenidate: Clinical update. Critical Public Health, 10, 81-86.
4. Baldwin, S. & Cooper, P. (2000). How should ADHD be treated? The Psychologist, 13, 598-602.
5. Barkley, R. A. et al. (2002). International Consensus Statement on ADHD. Clinical Child and Family Psychology Review, 5, 89-111.
6. Boyle, M. (2002). It's all done with smoke and mirrors: Or how to create the illusion of a schizophrenic brain disease. Clinical Psychology, 12, 9-19.
7. Breggin, P. (1994). The war against children: How the drugs programmes and theories of the psychiatric establishment are threatening America's children with a medical 'cure' for violence. New York: St Martin's Press.
8. Breggin, P. (2002). The Ritalin fact book. Cambridge, MA: Perseus Publishing.
9. Burton, B. & Rowell, A. (2003). Unhealthy spin. British Medical Journal, 326,1205-1207.
10. Curtis, T. (2004). Doctor in child drug treatment row to face GMC. Scotland on Sunday, 18 January.
11. Diller, L.H. (1998). Running on Ritalin. New York: Bantam.
12. Goodman, R. (1997). An over extended remit. British Medical Journal, 314, 813-814.
13. Herxheimer, A. (2003). Relationships between pharmaceutical industry and patients organizations. British Medical Journal, 326, 1208-1210.
14. Hey, V., Leonard, D., Daniels, H. & Smith, M. (1998). Boys' underachievement, special needs practices and questions of equity. In D. Epstein, J. Elwood, V. Hey & J. Maw (Eds.) Failing boys? Issues in gender and underachievement. Buckingham: Open University Press.
15. Joughin, C. & Zwi, M. (1999). Focus on the use of stimulants in children with Attention Deficit Hyper-activity Disorder. Primary evidence-base Briefing, 1. London: Royal College of Psychiatrists Research Unit.
16. Karon, B.P. (1994). Problems of psychotherapy under managed care. Psychotherapy in Private Practice, 2, 55-63.
17. Koriath, U., Gualtieri, M.D., Van Bourgondien, M.E., Quade, D. & Werry, J.S. (1985). Construct validity of clinical diagnosis in pediatric psychiatry: Relationship among measures. Journal of the American Academy of Child Psychiatry, 24, 429-436.
18. LeFever, G.B., Dawson, K.V. & Morrow, A.D. (1999). The extent of drug therapy for attention deficit hyper-activity disorder among children in public schools. American Journal of Public Health, 89, 1359-1364.
19. Mann, E.M., Ikeda, Y., Mueller, CW., Takahashi, A., Tao, K.T., Humris, E., Li, B.L. & Chin, D. (1992). Cross-cultural differences in rating hyperactive-disruptive behaviours in children. American Journal of Psychiatry, 149, 1539-1542.
20. McGuinness, D. (1989). Attention Deficit Disorder, the Emperor's new clothes, Animal 'Pharm' and other fiction. In S. Fisher & R. Greenberg (Eds.) The limits of biological treatments for psychological distress: Comparisons with psychotherapy and placebo. Hillsdale, NJ: Lawrence Erlbaum Associates.
21. Olfson, M., Marcus, S.C., Weissman, M.M. & Jensen, P.S. (2002). National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 514-521.
22. O'Meara, P. (2003). Putting power back in parental hands. Insight Magazine, 28 April 2003.
23. Reid, R., Maag, JW. & Vasa, S.F. (1993). Attention Deficit Hyperactivity Disorder as a disability category: A critique. Exceptional Children, 60,198-214.
24. Rutter, M. (1983). Behavioural studies: Questions of findings on the concept of a distinctive syndrome. In M. Rutter (Ed.) Developmental neuropsychology. New York: Guilford.
25. Schachter, H., Pham, B., King, J., Langford, S. & Moher, D. (2001). How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Canadian Medical Association Journal, 165,1475-1488.
26. Sonuga-Barke, E.J.S., Minocha, K., Taylor, E.A. & Sandberg, S. (1993). Inter-ethnic bias in teachers' ratings of childhood hyperactivity. British Journal of Developmental Psychology, 11, 187-200.
27. Taylor, E. (1989) On the epidemiology of hyperactivity. In T. Sagnolden & T. Archer (Eds.) Attention Deficit Disorder: Clinical and basic research. Hillsdale, NJ: Lawrence Erlbaum.
28. Timimi, S. (2002). Pathological child psychiatry and the medicalization of childhood. Hove: Brunner-Routledge.
29. Timimi, S. et al. (2004). A critique of the international consensus statement on ADHD. Clinical Child and Family Psychology Review, 7, 59-63.
30. Timimi, S. & Taylor, E. (2004). ADHD is best understood as a cultural construct. British Journal of Psychiatry, 184, 8-9.
31. Wasserman, R.C., Kelleher, K.J., Bocian, A., Baber, A., Childs, C.E., Indacochea, F., Stulp, C. & Gardner, W.P. (1999). Identification of attentional and hyperactivity problems in primary care: A report from pediatric research in office settings and the ambulatory sentinel practice network. Pediatrics, 103, E38.
32. Wright, O. (2003). Ritalin use and abuse fears. The Times, 28 July, 3.
33. Zito, J.M., Safer, D.J., Dosreis, S., Gardner, J.F., Boles, J, & Lynch, F. (2000). Trends in prescribing of psychotropic medication in pre-schoolers. Journal of the American Medical Association, 283, 1025-1030.